Filing Details

Accession Number:
0000914190-16-000918
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-02 16:28:17
Reporting Period:
2016-11-30
Filing Date:
2016-12-02
Accepted Time:
2016-12-02 16:28:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1196298 Nephros Inc NEPH Surgical & Medical Instruments & Apparatus (3841) 133971809
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411726 Daron Evans C/O Nephros, Inc.
41 Grand Avenue
River Edge NJ 07661
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-30 931 $0.29 284,140 No 4 P Direct
Common Stock Acquisiton 2016-12-01 40,599 $0.32 324,739 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $0.46 2024-03-26 75,361 75,361 Direct
Common Stock Stock Option (Right to Buy) $0.60 2025-04-15 764,468 764,468 Direct
Common Stock Common Stock Warrants (Right to Buy) $0.30 2016-06-03 2021-06-03 40,000 40,000 Indirect
Common Stock Common Stock Warrants (Right to Buy) $0.30 2016-06-03 2021-06-03 10,000 10,000 Indirect
Common Stock Common Stock Warrants (Right to Buy) $0.30 2016-06-03 2021-06-03 10,000 10,000 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-03-26 75,361 75,361 Direct
2025-04-15 764,468 764,468 Direct
2021-06-03 40,000 40,000 Indirect
2021-06-03 10,000 10,000 Indirect
2021-06-03 10,000 10,000 Indirect
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.315 to $0.33 inclusive. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Fully exercisable.
  3. On 4/15/2015, the Reporting Person was granted an option to purchase up to 2,184,193 shares of common stock of the Company. 35% of the shares subject to the option (relating to a total of 764,468 shares) vest quarterly in 16 equal amounts, commencing on 6/30/2015. 15% of the shares subject to the option will vest, if ever, upon the listing of the Company's common stock on NASDAQ, NYSE, or such other exchange as the Board may later determine. The remaining 50% of the shares subject to the option will vest, if ever, upon the Company's achievement of certain annual revenue milestones as specified in that certain Employment Agreement dated 4/15/2015 between the Reporting Person and the Company.
  4. The reporting person is a managing director of the LLC that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.